You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 5, Issue 3

September 2017 - 15 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

  • Review
  • Open Access
21 Citations
8,860 Views
18 Pages

20 September 2017

Ebola virus disease (EVD) is a serious illness that causes severe disease in humans and non-human primates (NHPs) and has mortality rates up to 90%. EVD is caused by the Ebolavirus and currently there are no licensed therapeutics or vaccines to treat...

  • Case Report
  • Open Access
2 Citations
15,491 Views
5 Pages

An Atypical Local Vesicular Reaction to the Yellow Fever Vaccine

  • Robert H. Wauters,
  • Camellia L. Hernandez and
  • Maureen M. Petersen

19 September 2017

Yellow fever vaccine is a live attenuated viral inoculation indicated for patients traveling to endemic areas. The vaccine is generally well tolerated with minimal adverse effects. Typical side effects include malaise, pain at the injection site, and...

  • Article
  • Open Access
17 Citations
8,889 Views
13 Pages

Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities

  • Peter Mastrangelo,
  • Michael J. Norris,
  • Wenming Duan,
  • Edward G. Barrett,
  • Theo J. Moraes and
  • Richard G. Hegele

19 September 2017

Nucleolin (NCL) has been reported as a cellular receptor for the human respiratory syncytial virus (RSV). We studied the effects of re-purposing AS1411, an anti-cancer compound that binds cell surface NCL, as a possible novel strategy for RSV therapy...

  • Review
  • Open Access
116 Citations
15,131 Views
20 Pages

Current Status of Rift Valley Fever Vaccine Development

  • Bonto Faburay,
  • Angelle Desiree LaBeaud,
  • D. Scott McVey,
  • William C. Wilson and
  • Juergen A. Richt

19 September 2017

Rift Valley Fever (RVF) is a mosquito-borne zoonotic disease that presents a substantial threat to human and public health. It is caused by Rift Valley fever phlebovirus (RVFV), which belongs to the genus Phlebovirus and the family Phenuiviridae with...

  • Article
  • Open Access
14 Citations
5,816 Views
17 Pages

Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment

  • Erika S. Hue,
  • Eric A. Richard,
  • Christine I. Fortier,
  • Guillaume D. Fortier,
  • Romain Paillot,
  • Rudiger Raue and
  • Stéphane L. Pronost

19 September 2017

Equine herpesviruses (EHV) infect horses early during life and the persistence of these viruses through establishment of latency represents a real risk. A better understanding of the immune response to EHV infection is necessary to improve our method...

  • Review
  • Open Access
32 Citations
7,215 Views
9 Pages

A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections

  • Mackenzie Henderson,
  • Amanda Bragg,
  • Germin Fahim,
  • Monica Shah and
  • Evelyn R. Hermes-DeSantis

2 September 2017

This review aims to evaluate the literature on the safety and efficacy of novel toxoid vaccines for the prophylaxis of Clostridium difficile infections (CDI) in healthy adults. Literature searches for clinical trials were performed through MEDLINE, C...

  • Review
  • Open Access
57 Citations
13,818 Views
26 Pages

1 September 2017

Both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are a major global healthcare problem with more than 240 million and 70 million infected, respectively. Both viruses persist within the liver and result in progressive liver disease,...

  • Review
  • Open Access
121 Citations
15,864 Views
38 Pages

The TRIMendous Role of TRIMs in Virus–Host Interactions

  • Sarah Van Tol,
  • Adam Hage,
  • Maria Isabel Giraldo,
  • Preeti Bharaj and
  • Ricardo Rajsbaum

22 August 2017

The innate antiviral response is integral in protecting the host against virus infection. Many proteins regulate these signaling pathways including ubiquitin enzymes. The ubiquitin-activating (E1), -conjugating (E2), and -ligating (E3) enzymes work t...

  • Feature Paper
  • Article
  • Open Access
36 Citations
8,268 Views
12 Pages

Challenges in Estimating Vaccine Coverage in Refugee and Displaced Populations: Results From Household Surveys in Jordan and Lebanon

  • Timothy Roberton,
  • William Weiss,
  • The Jordan Health Access Study Team,
  • The Lebanon Health Access Study Team and
  • Shannon Doocy

12 August 2017

Ensuring the sustained immunization of displaced persons is a key objective in humanitarian emergencies. Typically, humanitarian actors measure coverage of single vaccines following an immunization campaign; few measure routine coverage of all vaccin...

  • Article
  • Open Access
14 Citations
8,277 Views
17 Pages

Vaccine development relies on testing vaccine candidates in animal models. However, results from animals cannot always be translated to humans. Alternative ways to screen vaccine candidates before clinical trials are therefore desirable. Dendritic ce...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X